JurisdictionsTopicsUpdatesWorkflowsCompareChat with ExpertMarketplacePricing
๐Ÿ‡จ๐Ÿ‡ฟ๐Ÿญ

GMP Pathway

EU-GMP requirements for the Czech market

GMP Verified 2026-04-20

Workflow steps

  1. GMP Assessment
    Czech Republic is an EU member โ€” EU-GMP Part I required for all finished medicinal cannabis. SรšKL participates fully in the EU GMP inspection network.
  2. Finished product or API?
    Finished product requires EU-GMP Part I. API/bulk supply to a Czech finisher may use EU-GMP Part II.
  3. EU-GMP Part I Required โ€” All finished imports
    Mandatory for all finished medicinal cannabis distributed to Czech pharmacies. Certificate from any EEA authority or PIC/S-recognised body accepted.
    • EEA authority or PIC/S recognised certificate
    • Cannabis scope explicitly stated
    • QP at Czech importer certifies each batch
  4. EU-GMP Part II โ€” API to Czech finisher
    Accepted for bulk API supply to a Czech Pharmaceutical Act ยง63-licensed manufacturer.
    • Czech licensed manufacturer takes Part I responsibility
    • Czech QP releases finished batch
  5. Czech QP Batch Release
    EU Qualified Person named on Czech importer's wholesale authorization certifies each batch.
    • QP named on SรšKL wholesale authorization
    • Full batch record reviewed
    • QP legally liable for each released batch
  6. Released for Czech Supply โœ“
    QP-certified batch available for distribution to Czech pharmacies.
Regulatory HierarchyProduct Registration